The big picture… or the microscopic details. DynPort Vaccine Company (DVC) can provide expert guidance at any stage in the development life cycle, or manage the entire program.
DVC manages product development programs for U.S. government agencies, and provides technical, consulting and project management services to companies in the biotechnology and pharmaceutical industries. >learn more
Answers for Success
In this business, experience matters. DVC has a track record of proven success. We ask the right questions, and work with our clients to develop programs that fit your needs exactly.
Give your program the best chance for success. If you have a need in biopharmaceutical product development, DVC has an answer. We guarantee the best answer for you. >contact us
NEWS
Biodefense Q&A series - Part 2 of 3
DVC President Dr. Robert V. House discusses current biodefense industry trends. >learn more
DVC Wins $32.3 Million NIAID Contract
DVC and Quintiles team to establish and operate a Phase 1 clinical trial unit for infectious disease therapeutics. >learn more
EVENTS & FEATURES
American Society of Tropical Medicine and Hygiene Meeting
Dec. 7-11 New Orleans, LA Hear Dr. Shannon Martin present information on the Venezuelan equine encephalitis vaccine. >learn more
Case study: Botulinum neurotoxin vaccine
DVC works with CBMS on a vaccine against botulinum serotypes A and B. (PDF) >learn more
